キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/09/12 | 4,490 | 4,525 | 4,470 | 4,470 | -55 | -1.2% | 67,200 |
2025/09/11 | 4,535 | 4,560 | 4,500 | 4,525 | -25 | -0.5% | 40,200 |
2025/09/10 | 4,530 | 4,570 | 4,500 | 4,550 | +20 | +0.4% | 46,200 |
2025/09/09 | 4,550 | 4,555 | 4,500 | 4,530 | -10 | -0.2% | 80,200 |
2025/09/08 | 4,565 | 4,565 | 4,515 | 4,540 | -5 | -0.1% | 41,900 |
2025/09/05 | 4,510 | 4,555 | 4,470 | 4,545 | +65 | +1.5% | 60,600 |
2025/09/04 | 4,550 | 4,550 | 4,480 | 4,480 | -15 | -0.3% | 93,200 |
2025/09/03 | 4,410 | 4,495 | 4,410 | 4,495 | +115 | +2.6% | 80,200 |
2025/09/02 | 4,345 | 4,430 | 4,345 | 4,380 | +55 | +1.3% | 72,900 |
2025/09/01 | 4,330 | 4,360 | 4,305 | 4,325 | ±0 | ±0% | 38,800 |
2025/08/29 | 4,270 | 4,335 | 4,265 | 4,325 | +30 | +0.7% | 74,100 |
2025/08/28 | 4,300 | 4,320 | 4,265 | 4,295 | -15 | -0.3% | 44,300 |
2025/08/27 | 4,295 | 4,315 | 4,260 | 4,310 | +15 | +0.3% | 72,700 |
2025/08/26 | 4,285 | 4,330 | 4,270 | 4,295 | +30 | +0.7% | 79,200 |
2025/08/25 | 4,300 | 4,310 | 4,265 | 4,265 | -65 | -1.5% | 51,100 |
2025/08/22 | 4,305 | 4,330 | 4,280 | 4,330 | +40 | +0.9% | 81,000 |
2025/08/21 | 4,320 | 4,320 | 4,260 | 4,290 | -30 | -0.7% | 59,000 |
2025/08/20 | 4,345 | 4,365 | 4,290 | 4,320 | -25 | -0.6% | 55,000 |
2025/08/19 | 4,340 | 4,345 | 4,310 | 4,345 | +25 | +0.6% | 38,600 |
2025/08/18 | 4,290 | 4,335 | 4,285 | 4,320 | +30 | +0.7% | 55,100 |
2025/08/15 | 4,315 | 4,335 | 4,265 | 4,290 | -15 | -0.3% | 56,400 |
2025/08/14 | 4,330 | 4,330 | 4,260 | 4,305 | -30 | -0.7% | 65,700 |
2025/08/13 | 4,345 | 4,375 | 4,300 | 4,335 | -15 | -0.3% | 48,300 |
2025/08/12 | 4,395 | 4,395 | 4,315 | 4,350 | -10 | -0.2% | 89,600 |
2025/08/08 | 4,505 | 4,515 | 4,330 | 4,360 | -165 | -3.6% | 121,900 |
2025/08/07 | 4,455 | 4,590 | 4,455 | 4,525 | +25 | +0.6% | 65,300 |
2025/08/06 | 4,440 | 4,505 | 4,440 | 4,500 | +50 | +1.1% | 52,000 |
2025/08/05 | 4,420 | 4,475 | 4,375 | 4,450 | +5 | +0.1% | 60,500 |
2025/08/04 | 4,390 | 4,460 | 4,345 | 4,445 | +40 | +0.9% | 78,700 |
2025/08/01 | 4,450 | 4,475 | 4,390 | 4,405 | -60 | -1.3% | 121,900 |
2025/07/31 | 4,315 | 4,500 | 4,315 | 4,465 | +220 | +5.2% | 272,400 |
2025/07/30 | 4,070 | 4,305 | 4,060 | 4,245 | -60 | -1.4% | 300,600 |
2025/07/29 | 4,235 | 4,340 | 4,210 | 4,305 | +30 | +0.7% | 149,700 |
2025/07/28 | 4,310 | 4,340 | 4,275 | 4,275 | -55 | -1.3% | 77,600 |
2025/07/25 | 4,270 | 4,375 | 4,225 | 4,330 | +100 | +2.4% | 121,400 |
2025/07/24 | 4,225 | 4,260 | 4,185 | 4,230 | +60 | +1.4% | 83,800 |
2025/07/23 | 4,145 | 4,240 | 4,090 | 4,170 | +35 | +0.8% | 153,100 |
2025/07/22 | 4,160 | 4,250 | 4,135 | 4,135 | -85 | -2% | 65,300 |
2025/07/18 | 4,245 | 4,245 | 4,200 | 4,220 | -35 | -0.8% | 52,300 |
2025/07/17 | 4,190 | 4,270 | 4,190 | 4,255 | +70 | +1.7% | 81,600 |
2025/07/16 | 4,135 | 4,195 | 4,135 | 4,185 | +60 | +1.5% | 84,800 |
2025/07/15 | 4,130 | 4,145 | 4,095 | 4,125 | +10 | +0.2% | 52,100 |
2025/07/14 | 4,090 | 4,125 | 4,070 | 4,115 | +35 | +0.9% | 58,200 |
2025/07/11 | 4,045 | 4,110 | 4,045 | 4,080 | +55 | +1.4% | 61,200 |
2025/07/10 | 4,010 | 4,025 | 3,970 | 4,025 | +15 | +0.4% | 65,200 |
2025/07/09 | 3,975 | 4,050 | 3,975 | 4,010 | +45 | +1.1% | 69,000 |
2025/07/08 | 3,990 | 3,995 | 3,940 | 3,965 | -20 | -0.5% | 54,300 |
2025/07/07 | 4,000 | 4,015 | 3,980 | 3,985 | -5 | -0.1% | 33,800 |
2025/07/04 | 3,985 | 4,025 | 3,985 | 3,990 | +5 | +0.1% | 52,800 |
2025/07/03 | 4,020 | 4,025 | 3,920 | 3,985 | -55 | -1.4% | 62,200 |
1~
50
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 447,000円 | +3.6% | - | 2.68% | 15.06倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
日本新薬 | 329,300円 | +3.6% | -15.3% | 3.77% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 173,400円 | +5.0% | +1.5% | 0.00% | 14.84倍 | 4.18倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サンバイオ | 239,300円 | - | - | 0.00% | - | 110.84倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 389,900円 | -6.4% | -71.8% | 4.87% | 43.42倍 | 0.97倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム